Click to Enlarge
Facebook
Twitter
The Financial Times focuses on the pause of the Johnson and Johnson vaccine rollout in Europe as US agencies review concerns over rare blood clots – similar to those seen in the AstraZeneca jab. The US review is due to be complete in “a matter of days”, the paper says, and Johnson and Johnson took the decision itself to halt the use of its jab in Europe.

Financial Times Front Page 27th of December 2024

The Russian military has been accused of shooting down an Azerbaijani passenger aircraft, sparking controversy and tension as Western nations, including the UK and US, challenge Kremlin denials and highlight the incident’s potential breach of international security.

Read More »

Financial Times Front Page 23rd of December 2024

Nick Candy has pledged to help Reform UK disrupt the political landscape by supporting policies aimed at reducing the influence of established parties, with plans to introduce a law on fair donations and the backing of affluent supporters, positioning the party as a formidable force in upcoming elections.

Read More »